Baochun Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Baochun Lu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Weiguang Zhang
Affiliation Department of Molecular Medicine and Clinical Laboratory, Shaoxing Second Hospital, Shaoxing, Zhejiang, China
8 shared publicationsJianhua Yu
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang Province, China
5 shared publicationsChenhao Tong
Affiliations Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, Department of Hepatobiliary Surgery, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, Zhejiang, China, Shaoxing Key Laboratory of Minimally Invasive Abdominal Surgery and Precise Treatment of Tumor, Shaoxing, Zhejiang, China
4 shared publicationsJiandong Li
Affiliations Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, Department of Hepatobiliary Surgery, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, Zhejiang, China, Shaoxing Key Laboratory of Minimally Invasive Abdominal Surgery and Precise Treatment of Tumor, Shaoxing, Zhejiang, China
4 shared publications- Jianhua Yu
Medical research center, Shaoxing People's Hospital, Shaoxing, Zhejiang 312000, China; Department of Hepatobiliary Surgery, Shaoxing People's Hospital, Shaoxing, Zhejiang 312000, China
4 shared publications Weiguo Lin
Department of Hepatobiliary Surgery, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, Zhejiang 312000, P.R. China
4 shared publications
Latest Publications
- Open Access
- 11 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4483-4484
Splenic rupture mimicking acute abdomen caused by giant hydronephrosis: A thorny case
- 11 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4483-4484
Open AccessSplenic rupture mimicking acute abdomen caused by giant hydronephrosis: A thorny case
- Open Access
- 2 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4455-4457
Hemorrhage after pancreaticoduodenectomy caused by migration of pancreatic duct stent: A case series
- 2 May 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (10) , 4455-4457
Open AccessHemorrhage after pancreaticoduodenectomy caused by migration of pancreatic duct stent: A case series
- Open Access
- 30 June 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (6)
Confusing delayed hematemesis, unusual arterial hemorrhage after pancreaticoduodenectomy: a case report
Pancreaticoduodenectomy (PD) is one of the most complex surgeries and is associated with a high rate of complications, including bleeding, delayed gastric emptying (DGE), and pancreatic fistula. Although the frequency of postoperative hemorrhage is not high, this complication results in severe adverse outcomes. A 67-year-old man was diagnosed with pancreatic cancer and underwent PD. On the tenth day after surgery, he developed hypovolemic shock with hematemesis. Urgent digital subtraction angiography identified the bleeding artery as the jejunal mesenteric artery at the afferent loop, and the bleeding artery was embolized with two coils. After digital subtraction angiography, the patient had an uneventful recovery with no further complications. Therefore, we concluded that it is possible that bleeding may occur in the afferent loop when hemorrhage occurs after PD.
- 30 June 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (6)
Open AccessConfusing delayed hematemesis, unusual arterial hemorrhage after pancreaticoduodenectomy: a case report
Pancreaticoduodenectomy (PD) is one of the most complex surgeries and is associated with a high rate of complications, including bleeding, delayed gastric emptying (DGE), and pancreatic fistula. Although the frequency of postoperative hemorrhage is not high, this complication results in severe adverse outcomes. A 67-year-old man was diagnosed with pancreatic cancer and underwent PD. On the tenth day after surgery, he developed hypovolemic shock with hematemesis. Urgent digital subtraction angiography identified the bleeding artery as the jejunal mesenteric artery at the afferent loop, and the bleeding artery was embolized with two coils. After digital subtraction angiography, the patient had an uneventful recovery with no further complications. Therefore, we concluded that it is possible that bleeding may occur in the afferent loop when hemorrhage occurs after PD.
- Open Access
- 21 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0266738
Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis
Gallbladder cancer (GBC) is the most common biliary tract malignancy with a dismal prognosis. The development of new drugs may help to improve prognosis. This study found that fangchinoline, a bisbenzylisoquinoline alkaloids, inhibited the proliferation and clone formation of GBC cells in a dose-dependent manner. Moreover, Hoechst staining, TUNEL assays, and flow cytometry demonstrated that fangchinoline effectively induced apoptosis in GBC cells. Further studies found that an anti-apoptotic pathway, the PI3K/Akt/XIAP axis, was significantly inhibited in GBC cells after treating with fangchinoline. Finally, we confirmed that fangchinoline restrained xenograft tumor growth in vivo. Our findings indicate that fangchinoline can be considered a potential drug for GBC treatment.
- 21 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0266738
Open AccessFangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis
Gallbladder cancer (GBC) is the most common biliary tract malignancy with a dismal prognosis. The development of new drugs may help to improve prognosis. This study found that fangchinoline, a bisbenzylisoquinoline alkaloids, inhibited the proliferation and clone formation of GBC cells in a dose-dependent manner. Moreover, Hoechst staining, TUNEL assays, and flow cytometry demonstrated that fangchinoline effectively induced apoptosis in GBC cells. Further studies found that an anti-apoptotic pathway, the PI3K/Akt/XIAP axis, was significantly inhibited in GBC cells after treating with fangchinoline. Finally, we confirmed that fangchinoline restrained xenograft tumor growth in vivo. Our findings indicate that fangchinoline can be considered a potential drug for GBC treatment.
- Open Access
- 23 February 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
Gallbladder cancer is the most common malignant tumor of the biliary system and is characterized by difficulty to diagnose in early stages, a high degree of malignancy, and poor prognosis. Finding new drugs may improve the prognosis for this dismal cancer. Herein, we investigated the potential application of pterostilbene (PTS) against gallbladder cancer in vivo and in vitro. PTS potently inhibited cell proliferation, migration and invasion of gallbladder cancer cells. Moreover, PTS also had a function of inducing apoptosis in vitro. Meanwhile, PTS reversed EMT with a correlated inhibition of PI3K/Akt activation. Tumor xenograft models showed that PTS inhibited tumor growth and had low toxicity in vivo, which were consistent with the in vitro data. These findings indicate that PTS arrests cell growth through inhibition of PI3K/AKT signaling and is a potential drug for the therapy of gallbladder cancer.
- 23 February 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Open AccessPterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
Gallbladder cancer is the most common malignant tumor of the biliary system and is characterized by difficulty to diagnose in early stages, a high degree of malignancy, and poor prognosis. Finding new drugs may improve the prognosis for this dismal cancer. Herein, we investigated the potential application of pterostilbene (PTS) against gallbladder cancer in vivo and in vitro. PTS potently inhibited cell proliferation, migration and invasion of gallbladder cancer cells. Moreover, PTS also had a function of inducing apoptosis in vitro. Meanwhile, PTS reversed EMT with a correlated inhibition of PI3K/Akt activation. Tumor xenograft models showed that PTS inhibited tumor growth and had low toxicity in vivo, which were consistent with the in vitro data. These findings indicate that PTS arrests cell growth through inhibition of PI3K/AKT signaling and is a potential drug for the therapy of gallbladder cancer.
- Open Access
- 21 January 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (3) , 1
Inhibition of heat shock protein 90 alleviates cholestatic liver injury by decreasing IL‑1β and IL‑18 expression
Severe cholestatic liver injury diseases, such as obstructive jaundice and the subsequent acute obstructive cholangitis, are induced by biliary tract occlusion. Heat shock protein 90 (HSP90) inhibitors have been demonstrated to be protective for various organs. The potential of HSP90 inhibitors in the treatment of cholestatic liver injury, however, remains unclear. In the present study, rat models of bile duct ligation (BDL) were established, the HSP90 inhibitor 17‑dimethylamino‑ethylamino‑17‑demethoxygeldanamycin (17‑DMAG) was administered, and its ability to ameliorate the cholestasis‑induced liver injuries was evaluated. In the BDL rat models and clinical samples, increased HSP90 expression was observed to be associated with cholestatic liver injury. Furthermore, 17‑DMAG alleviated cholestasis‑induced liver injury in the rat models, as revealed by the assessment of pathological changes and liver function. In addition, 17‑DMAG protected hepatocytes against cholestatic injury in vitro. Further assays indicated that 17‑DMAG administration prevented cholestasis‑induced liver injury in the rats by decreasing the expression of interleukin (IL)‑1β and IL‑18. Moreover, 17‑DMAG also decreased the cholestasis‑induced upregulation of IL‑1β and IL‑18 in liver sinusoidal endothelial cells in vitro. In conclusion, the HSP90 inhibitor 17‑DMAG is able to prevent liver injury in rats with biliary obstruction, and this phenomenon is associated with the reduction of IL‑1β and IL‑18 expression.
- 21 January 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (3) , 1
Open AccessInhibition of heat shock protein 90 alleviates cholestatic liver injury by decreasing IL‑1β and IL‑18 expression
Severe cholestatic liver injury diseases, such as obstructive jaundice and the subsequent acute obstructive cholangitis, are induced by biliary tract occlusion. Heat shock protein 90 (HSP90) inhibitors have been demonstrated to be protective for various organs. The potential of HSP90 inhibitors in the treatment of cholestatic liver injury, however, remains unclear. In the present study, rat models of bile duct ligation (BDL) were established, the HSP90 inhibitor 17‑dimethylamino‑ethylamino‑17‑demethoxygeldanamycin (17‑DMAG) was administered, and its ability to ameliorate the cholestasis‑induced liver injuries was evaluated. In the BDL rat models and clinical samples, increased HSP90 expression was observed to be associated with cholestatic liver injury. Furthermore, 17‑DMAG alleviated cholestasis‑induced liver injury in the rat models, as revealed by the assessment of pathological changes and liver function. In addition, 17‑DMAG protected hepatocytes against cholestatic injury in vitro. Further assays indicated that 17‑DMAG administration prevented cholestasis‑induced liver injury in the rats by decreasing the expression of interleukin (IL)‑1β and IL‑18. Moreover, 17‑DMAG also decreased the cholestasis‑induced upregulation of IL‑1β and IL‑18 in liver sinusoidal endothelial cells in vitro. In conclusion, the HSP90 inhibitor 17‑DMAG is able to prevent liver injury in rats with biliary obstruction, and this phenomenon is associated with the reduction of IL‑1β and IL‑18 expression.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 3235786
Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells
ARAF is a member of the RAF kinase family that is necessary for mitogen‐activated protein kinase (MAPK) activation in various malignancies, including lung, colorectal, pancreatic, and breast cancers. As the most common biliary tract tumor, gallbladder cancer (GBC) seriously harms human health while the function of ARAF in GBC remains elusive. Here, we found that ARAF expression was upregulated in gallbladder cancer tissues. In vitro, ARAF silencing mediated by RNA interference effectively inhibited cell proliferation, colony formation, migration, and invasion of GBC cells. Moreover, knocking down ARAF suppressed tumor growth in vivo. Our results indicated that ARAF functions as an oncogene in GBC and, thus, could be a potential therapeutic target for GBC.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 3235786
Open AccessSilencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells
ARAF is a member of the RAF kinase family that is necessary for mitogen‐activated protein kinase (MAPK) activation in various malignancies, including lung, colorectal, pancreatic, and breast cancers. As the most common biliary tract tumor, gallbladder cancer (GBC) seriously harms human health while the function of ARAF in GBC remains elusive. Here, we found that ARAF expression was upregulated in gallbladder cancer tissues. In vitro, ARAF silencing mediated by RNA interference effectively inhibited cell proliferation, colony formation, migration, and invasion of GBC cells. Moreover, knocking down ARAF suppressed tumor growth in vivo. Our results indicated that ARAF functions as an oncogene in GBC and, thus, could be a potential therapeutic target for GBC.
- Open Access
- 6 December 2019
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 7 (23) , 4106-4110
Complete duodenal obstruction induced by groove pancreatitis: A case report
BACKGROUND Groove pancreatitis (GP) is a type of chronic pancreatitis occurring in an anatomic area between the duodenum, head of the pancreas, and common bile duct. Duodenal obstruction is always caused by malignant pancreatic diseases, such as pancreatic head carcinoma, while is rarely induced by benign pancreatic diseases, such as pancreatitis. CASE SUMMARY A 39-year-old man presented with a 1-mo history of upper abdominal discomfort. His concomitant symptoms were abdominal distension, postprandial nausea, and vomiting. Contrast-enhanced computed tomography of the abdomen showed thickening of the intestinal wall with enhancement of the descending segment of the duodenum, which could not be clearly differentiated from the head of the pancreas. Upper gastrointestinal radiographs and gastrointestinal endoscopy showed a complete obstruction of the descending duodenum. An operation found that a 3-cm mass was located in the "groove part" of the pancreas and oppressing the descending duodenum. Pancreaticoduodenectomy was performed to relieve the obstruction and thoroughly remove the pancreatic lesions. The pathologic diagnosis was pancreatitis. The patient had an uneventful recovery with no complications. CONCLUSION Because of the special location and the contracture induced by long-term chronic inflammation, our case reminds surgeons that some benign pancreatic diseases, such as GP, can also present with symptoms similar to those of pancreatic cancer. This knowledge can help to avoid an unnecessary radical operation.
- 6 December 2019
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 7 (23) , 4106-4110
Open AccessComplete duodenal obstruction induced by groove pancreatitis: A case report
BACKGROUND Groove pancreatitis (GP) is a type of chronic pancreatitis occurring in an anatomic area between the duodenum, head of the pancreas, and common bile duct. Duodenal obstruction is always caused by malignant pancreatic diseases, such as pancreatic head carcinoma, while is rarely induced by benign pancreatic diseases, such as pancreatitis. CASE SUMMARY A 39-year-old man presented with a 1-mo history of upper abdominal discomfort. His concomitant symptoms were abdominal distension, postprandial nausea, and vomiting. Contrast-enhanced computed tomography of the abdomen showed thickening of the intestinal wall with enhancement of the descending segment of the duodenum, which could not be clearly differentiated from the head of the pancreas. Upper gastrointestinal radiographs and gastrointestinal endoscopy showed a complete obstruction of the descending duodenum. An operation found that a 3-cm mass was located in the "groove part" of the pancreas and oppressing the descending duodenum. Pancreaticoduodenectomy was performed to relieve the obstruction and thoroughly remove the pancreatic lesions. The pathologic diagnosis was pancreatitis. The patient had an uneventful recovery with no complications. CONCLUSION Because of the special location and the contracture induced by long-term chronic inflammation, our case reminds surgeons that some benign pancreatic diseases, such as GP, can also present with symptoms similar to those of pancreatic cancer. This knowledge can help to avoid an unnecessary radical operation.
- Open Access
- 22 April 2019
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 19 (6) , 5177-5184
Molecular hydrogen accelerates the reversal of acute obstructive cholangitis‑induced liver dysfunction by restoring gap and tight junctions
Gap junctions (GJs) and tight junctions (TJs) are essential to maintain the function of hepatocytes. Changes in biliary tract pressure and the effect of lipopolysaccharide (LPS) may lead to acute obstructive cholangitis (AOC) and cause liver injury via GJ and TJ dysfunction. Hydrogen has been confirmed to have a protective role in various organs during pathological conditions and inflammation. The present study investigated the function of junction proteins and the potential application of H-2 in AOC-induced liver injury. An AOC rat model was established by LPS injection through a bile duct catheter, while the distal bile duct was closed. The catheter sealing caps were removed and bile was allowed to flow out from the catheters at 12 h after LPS infusion. The potential application of H-2 was studied in the AOC rat model with biliary drainage. It was observed that AOC induced the disruption of junction proteins of both GJs and TJs. H-2 administration reversed AOC-induced disruption of GJs and TJs after biliary drainage. The mechanism of this phenomenon suggests that H-2 may have effectively attenuated AOC-induced inflammatory and oxidative damage, and decreased matrix metalloproteinase activity. H-2 may accelerate the reversal of AOC-induced liver dysfunction, and this phenomenon may depend on reversing the inhibition of GJs and TJs.
- 22 April 2019
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 19 (6) , 5177-5184
Open AccessMolecular hydrogen accelerates the reversal of acute obstructive cholangitis‑induced liver dysfunction by restoring gap and tight junctions
Gap junctions (GJs) and tight junctions (TJs) are essential to maintain the function of hepatocytes. Changes in biliary tract pressure and the effect of lipopolysaccharide (LPS) may lead to acute obstructive cholangitis (AOC) and cause liver injury via GJ and TJ dysfunction. Hydrogen has been confirmed to have a protective role in various organs during pathological conditions and inflammation. The present study investigated the function of junction proteins and the potential application of H-2 in AOC-induced liver injury. An AOC rat model was established by LPS injection through a bile duct catheter, while the distal bile duct was closed. The catheter sealing caps were removed and bile was allowed to flow out from the catheters at 12 h after LPS infusion. The potential application of H-2 was studied in the AOC rat model with biliary drainage. It was observed that AOC induced the disruption of junction proteins of both GJs and TJs. H-2 administration reversed AOC-induced disruption of GJs and TJs after biliary drainage. The mechanism of this phenomenon suggests that H-2 may have effectively attenuated AOC-induced inflammatory and oxidative damage, and decreased matrix metalloproteinase activity. H-2 may accelerate the reversal of AOC-induced liver dysfunction, and this phenomenon may depend on reversing the inhibition of GJs and TJs.
- Open Access
- 25 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
SOCS1 regulates hepatic regenerative response and provides prognostic makers for acute obstructive cholangitis
Acute obstructive cholangitis (AOC) is a common and severe infectious diseases that occurs in an obstructed biliary system. The suppressors of cytokine signaling (SOCS) family include well-known negative regulators of cytokine receptor signaling. However, few studies have been conducted to determine their function in AOC. In this study, we showed that SOCS1 expression aberrantly changed and was associated with AOC prognosis in rat models. Decreased SOCS1 expression enhances regenerative response after biliary drainage (BD) resulting from AOC by upregulating hepatocyte growth factor (HGF) signaling. To detect SOCS1 expression in the liver less invasively and to predict the prognosis for AOC after BD, miR-221 and miR-222 were investigated. Ectopic SOCS1 expression indirectly decreases miR-221/222 expression through Met in vitro. An inverse correlation between SOCS1 expression and miR-221/222 expression in liver tissue or in serum was verified in rats. Serum from AOC patients showed that lower expression of circulating miR-221/222 after endoscopic nasobiliary drainage was associated with delayed restoration of liver function. Our results showed that SOCS1 regulates hepatic regenerative response, and indirectly detecting downstream molecules, such as miR-221/222, may provide prognostic makers for AOC.
- 25 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Open AccessSOCS1 regulates hepatic regenerative response and provides prognostic makers for acute obstructive cholangitis
Acute obstructive cholangitis (AOC) is a common and severe infectious diseases that occurs in an obstructed biliary system. The suppressors of cytokine signaling (SOCS) family include well-known negative regulators of cytokine receptor signaling. However, few studies have been conducted to determine their function in AOC. In this study, we showed that SOCS1 expression aberrantly changed and was associated with AOC prognosis in rat models. Decreased SOCS1 expression enhances regenerative response after biliary drainage (BD) resulting from AOC by upregulating hepatocyte growth factor (HGF) signaling. To detect SOCS1 expression in the liver less invasively and to predict the prognosis for AOC after BD, miR-221 and miR-222 were investigated. Ectopic SOCS1 expression indirectly decreases miR-221/222 expression through Met in vitro. An inverse correlation between SOCS1 expression and miR-221/222 expression in liver tissue or in serum was verified in rats. Serum from AOC patients showed that lower expression of circulating miR-221/222 after endoscopic nasobiliary drainage was associated with delayed restoration of liver function. Our results showed that SOCS1 regulates hepatic regenerative response, and indirectly detecting downstream molecules, such as miR-221/222, may provide prognostic makers for AOC.